Pembrolizumab plus pegylated liposomal Doxorubicin for Patients with Ovarian Cancer

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2021年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [1] Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
    Monk, Bradley J.
    Herzog, Thomas J.
    Kaye, Stanley B.
    Krasner, Carolyn N.
    Vermorken, Jan B.
    Muggia, Franco M.
    Pujade-Lauraine, Eric
    Lisyanskaya, Alla S.
    Makhson, Anatoly N.
    Rolski, Janusz
    Gorbounova, Vera A.
    Ghatage, Prafull
    Bidzinski, Mariusz
    Shen, Keng
    Ngan, Hextan Yuen-Sheung
    Vergote, Ignace B.
    Nam, Joo-Hyun
    Park, Youn Choi
    Lebedinsky, Claudia A.
    Poveda, Andres M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3107 - 3114
  • [2] Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
    Zhen Yuan
    Ying Zhang
    Dongyan Cao
    Keng Shen
    Qingshui Li
    Guonan Zhang
    Xiaohua Wu
    Manhua Cui
    Ying Yue
    Wenjun Cheng
    Li Wang
    Pengpeng Qu
    Guangshi Tao
    Jianqing Hou
    Lixin Sun
    Yuanguang Meng
    Guiling Li
    Changzhong Li
    Huirong Shi
    Yaqing Chen
    Journal of Ovarian Research, 14
  • [3] Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
    Yuan, Zhen
    Zhang, Ying
    Cao, Dongyan
    Shen, Keng
    Li, Qingshui
    Zhang, Guonan
    Wu, Xiaohua
    Cui, Manhua
    Yue, Ying
    Cheng, Wenjun
    Wang, Li
    Qu, Pengpeng
    Tao, Guangshi
    Hou, Jianqing
    Sun, Lixin
    Meng, Yuanguang
    Li, Guiling
    Li, Changzhong
    Shi, Huirong
    Chen, Yaqing
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [4] Pegylated liposomal doxorubicin in ovarian cancer
    Green, Andrew E.
    Rose, Peter G.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 229 - 239
  • [5] Trabectedin in combination with pegylated liposomal doxorubicin for patients with ovarian cancer
    Tavella, K.
    Villanucci, A.
    Vannini, L.
    Montelatici, S.
    Lavacchi, D.
    Boni, L.
    Tomcikova, D.
    Amunni, G.
    Mazzei, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Pegylated liposomal doxorubicin in ovarian cancer patients with renal compromise
    Basu, C. K.
    Mukhopadhyay, A.
    Pandey, R.
    Dey, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Pegylated liposomal doxorubicin in ovarian cancer treatment
    Nowak-Markwitz, Ewa
    GINEKOLOGIA POLSKA, 2009, 80 (08) : 615 - 619
  • [8] Pegylated liposomal Doxorubicin in Recurrent Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (11)
  • [9] Pegylated liposomal doxorubicin in the management of ovarian cancer
    Ferrandina, Gabriella
    Corrado, Giacomo
    Licameli, Angelo
    Lorusso, Domenica
    Fuoco, Gilda
    Pisconti, Salvatore
    Scambia, Giovanni
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 463 - 483
  • [10] Pegylated Liposomal Doxorubicin in the Management of Ovarian Cancer
    Ferrandina, Gabriella
    Petrillo, Marco
    Licameli, Angelo
    Fuoco, Gilda
    Scambia, Giovanni
    Corrado, Giacomo
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 261 - 270
12345